Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403)

The purpose of this study was to evaluate the efficacy of gefitinib and the feasibility of screening for epidermal growth factor receptor (EGFR) mutations among select patients with advanced non-small cell lung cancer (NSCLC). Stage IIIB/IV NSCLC, chemotherapy-naive patients or patients with recurre...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamura, K, Okamoto, I, Kashii, T, Negoro, S, Hirashima, T, Kudoh, S, Ichinose, Y, Ebi, N, Shibata, K, Nishimura, T, Katakami, N, Sawa, T, Shimizu, E, Fukuoka, J, Satoh, T, Fukuoka, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2266849/
https://www.ncbi.nlm.nih.gov/pubmed/18283321
http://dx.doi.org/10.1038/sj.bjc.6604249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2266849/
https://www.ncbi.nlm.nih.gov/pubmed/18283321
http://dx.doi.org/10.1038/sj.bjc.6604249

Ejemplares similares